Status:
COMPLETED
Efficacy and Safety of Valsartan Plus Hydrochlorothiazide in Patients With Slight Hypertension and Target Organ Damage
Lead Sponsor:
Federico II University
Conditions:
Hypertension
Ventricular Remodeling
Eligibility:
MALE
18-65 years
Phase:
PHASE4
Brief Summary
Patients with slight increase in blood pressure levels have an increased cardiovascular risk. In particular this has been demonstrated also in subjects with high-normal blood pressure in whom an exagg...
Eligibility Criteria
Inclusion
- Aged 18-65
- Gender Males
- High-normal blood pressure (130-139 mmHg or 85-89 mmHg)
- First degree hypertension (140-159 mmHg or 90-99 mmHg)
- Cardiac remodeling (left ventricular concentric hypertrophy
Exclusion
- Coronary artery disease
- Secondary hypertension
- Diabetes mellitus
- Incapacity to perform ergometry test
- Anemia (Hb \< 12.5g/dL)
- Cardiac valve disease
- Arrhythmia
Key Trial Info
Start Date :
March 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2008
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00687206
Start Date
March 1 2008
End Date
December 1 2008
Last Update
January 29 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of internal medicine University Federico II
Naples, Italy, 80131